company

Otsuka Pharmaceutical Development & Commercialization, Inc.

OtsukaOtsuka America PharmaceuticalOtsuka Beijing Research InstituteOtsuka Canada Pharmaceutical Inc.Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Europe LtdOtsuka Pharmaceutical, Inc., Philippines
as of 2026-07-01
Monitor thisAsk about this
at a glance
154 trials sponsored · 24 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

24 assets
AmisulprideAripiprazoleBrexpiprazole (Rexulti)OlanzapinePaliperidoneQuetiapineRisperidoneUlotaront14C-SEP-3801352mg conventional tablet, once-weekly tabletsAVP-786Any FDA approved antipsychotic agentAvatar therapyCognitive Behavioral TherapyD-Tect PatchDigital Medicine SystemIngestible Event Marker (IEM)MIND1 SystemMetforminMoxifloxacinNo TreatmentQuinidine GluconateSEP-380135moxifloxacin 400 mg

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
small molecule
drug
Aripiprazole
small molecule
drug
Brexpiprazole (Rexulti)
small molecule
drug
Olanzapine
small molecule
drug
Paliperidone
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Ulotaront
small molecule
drug